248 related articles for article (PubMed ID: 14987750)
1. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
2. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
3. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
4. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone.
Heijmen PS; Klis SF; De Groot JC; Smoorenburg GF
Hear Res; 1999 Feb; 128(1-2):27-39. PubMed ID: 10082280
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological evaluation of the hearing function following cisplatin administration].
Bogomol'skiĭ MR; D'iakonova IN; Rakhmanova IV; Sapozhnikov IaM; Stakhovskaia OR; Tikhomirov AM
Vestn Otorinolaringol; 2010; (3):24-6. PubMed ID: 20559247
[TBL] [Abstract][Full Text] [Related]
8. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
Sepmeijer JW; Klis SF
Hear Res; 2009 Jan; 247(1):34-9. PubMed ID: 18955125
[TBL] [Abstract][Full Text] [Related]
9. [Effects of perilymphatic perfusion with cisplatin on the cochlear potential in guinea pigs].
Wu DZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):202-4, 254. PubMed ID: 2076322
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
11. Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.
Wolters FL; de Vocht TF; Klis SF; Hamers FP; Smoorenburg GF
Hear Res; 2002 Oct; 172(1-2):110-7. PubMed ID: 12361873
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of intra-cochlear administration of methylprednisolone after acoustic trauma caused by gunshot noise in guinea pigs.
Sendowski I; Abaamrane L; Raffin F; Cros A; Clarençon D
Hear Res; 2006 Nov; 221(1-2):119-27. PubMed ID: 17008037
[TBL] [Abstract][Full Text] [Related]
13. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
O'Leary SJ; Klis SF
Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin and cisplatin ototoxicity in guinea pigs.
Taudy M; Syka J; Popelár J; Ulehlová L
Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
[TBL] [Abstract][Full Text] [Related]
16. Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
Xiong H; Chu H; Zhou X; Huang X; Cui Y; Zhou L; Chen J; Li J; Wang Y; Chen Q; Li Z
Lab Anim; 2011 Apr; 45(2):95-102. PubMed ID: 21216844
[TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
18. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.
van Ruijven MW; de Groot JC; Klis SF; Smoorenburg GF
Hear Res; 2005 Jul; 205(1-2):241-8. PubMed ID: 15953532
[TBL] [Abstract][Full Text] [Related]
19. Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose.
Klis SF; O'Leary SJ; Wijbenga J; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2002 Feb; 164(1-2):138-46. PubMed ID: 11950533
[TBL] [Abstract][Full Text] [Related]
20. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
Bielefeld EC
Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
